Literature DB >> 1061120

Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences.

D J Bucher, S S Li, J M Kehoe, E D Kilbourne.   

Abstract

The influenza virus hemagglutinin polypeptides, HA1 and HA2, have been purified by gel filtration in the presence of sodium dodecyl sulfate from a vaccine preparation of the recombinant strain Heq1N2. Use of this technique for purification of the hemagglutinin polypeptides eliminated the need for proteolytic agents for removal of the hemagglutinin from the virus particles and 100-300 mg of virus yielded 10-30 mg of viral protein per chromatographic cycle. Because proteolysis is not required to remove the spikes from the viral envelope, the envelope-embedded HA2 polypeptide was purified in its entirety for structural analysis. Amino-terminal sequence analysis of the smaller polypeptide, HA2, revealed a cyclic repetition of glycyl residues through the first 24 residues at every third to fourth position. The sequence through the first 10 residues was identical to that presented by Skehel and Waterfield for other type A influenza viruses [(1975) Proc. Nat. Acad. Sci. USA 72, 93-97]. The HA1 (Heq/) polypeptide, on the other hand, had different amino acids at three or four out of the first 10 residues of the amino-terminal sequence when compared to HA1 from H0, H1, or H2 subtypes (Skehel and Waterfield). The present study has demonstrated the feasibility of the use of vaccine virus as a source of large quantities of viral protein for determination of primary structure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1061120      PMCID: PMC335876          DOI: 10.1073/pnas.73.1.238

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Separation of anthranilate synthetase components I and II of Escherichia coli, Salmonella typhimurium, and Serratia marcescens and determination of their amino-terminal sequences by automatic Edman degradation.

Authors:  S L Li; J Hanlon; C Yanofsky
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

3.  Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

4.  Properties of an antigenic glycoprotein isolated from influenza virus hemagglutinin.

Authors:  E A Eckert
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

5.  Amino acid composition of polypeptides from influenza virus particles.

Authors:  W G Laver; N Baker
Journal:  J Gen Virol       Date:  1972-10       Impact factor: 3.891

6.  A 2 (N2) neuraminidase of the X-7 influenza virus recombinant: determination of molecular size and subunit composition of the active unit.

Authors:  D J Bucher; E D Kilbourne
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

7.  Reversible denaturation of enzymes by sodium dodecyl sulfate.

Authors:  K Weber; D J Kuter
Journal:  J Biol Chem       Date:  1971-07-25       Impact factor: 5.157

8.  Localization of two additional hypervariable regions in immunoglobulin heavy chains.

Authors:  J M Kehoe; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

9.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

10.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03
View more
  14 in total

1.  Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars.

Authors:  R T Schwarz; M F Schmidt; U Anwer; H D Klenk
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

2.  Detection of antibodies to influenza virus M protein by an enzyme-linked immunosorbent assay.

Authors:  M W Khan; D J Bucher; A K Koul; G Kalish; H Smith; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

3.  Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay.

Authors:  M W Khan; M Gallagher; D Bucher; C P Cerini; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

4.  Incorporation of influenza virus M-protein into liposomes.

Authors:  D J Bucher; I G Kharitonenkov; J A Zakomirdin; V B Grigoriev; S M Klimenko; J F Davis
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

5.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.

Authors:  R Dolin; B R Murphy; E A Caplan
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Purification of the influenza hemagglutinin glycoprotein and characterization of its carbohydrate components.

Authors:  J K Collins; C A Knight
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

8.  Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.

Authors:  G M Air
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion.

Authors:  A Gregoriades; B Frangione
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

10.  Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles.

Authors:  A Gregoriades
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.